CoreWeave, Inc.
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
CRWV$48.73-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in millions)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net loss | $(740) | $(315) |
| Adjustments to reconcile net loss to net cash provided by operating activities | ||
| Depreciation and amortization | 1,147 | 443 |
| Amortization of debt discounts and issuance costs and accretion of redemption premiums | 41 | 38 |
| Stock-based compensation expense | 153 | 184 |
| Non-cash lease expense | 167 | 67 |
| Deferred income taxes | 79 | 45 |
| Gain on fair value adjustments | — | (27) |
| Other non-cash reconciling items | 121 | 23 |
| Changes in operating assets and liabilities, net of effect of business acquisitions: | ||
| Accounts receivable | 1,042 | (639) |
| Prepaid expenses and other assets | (471) | 247 |
| Accounts payable and accrued expenses | 960 | 62 |
| Deferred revenue | 575 | (16) |
| Lease liabilities | (90) | (51) |
| Net cash provided by operating activities | $2,984 | $61 |
| Cash flows from investing activities: | ||
| Purchase of property and equipment, including capitalized internal-use software | $(7,695) | $(1,407) |
| Maturities and sales of marketable securities | 12 | 29 |
| Issuance of notes receivable | — | (55) |
| Other investing activities | (25) | — |
| Net cash used in investing activities | $(7,708) | $(1,433) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of debt, net | $3,290 | $785 |
| Repayments of debt | (1,335) | (271) |
| Issuance of common stock in a private placement, net of issuance costs | 1,985 | — |
| Proceeds from initial public offering, net of underwriting discounts and commissions | — | 1,423 |
| Redeemable convertible preferred stock cash dividends paid | — | (26) |
| Payment of tax withholdings on settlement of RSUs | — | (16) |
| Other financing activities | (26) | (41) |
| Net cash provided by financing activities | $3,914 | $1,854 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | $(810) | $482 |
| Cash, cash equivalents, and restricted cash—beginning of period | 4,130 | 2,035 |
| Cash, cash equivalents, and restricted cash—end of period | $3,320 | $2,517 |
| Supplemental disclosures of cash flow information: | ||
| Cash paid for interest, net of capitalized amounts | $364 | $142 |
| Non-cash investing and financing activities: | ||
| Liabilities related to property and equipment additions, including OEM financed additions | $4,592 | $2,019 |
| Reclassification of liabilities related to property and equipment additions to debt upon execution of OEM financing arrangements | 1,469 | — |
| Operating lease right-of-use assets acquired through lease liability | 1,988 | 536 |
| Conversion of redeemable convertible preferred stock in connection with initial public offering | — | 1,722 |
| Issuance of common stock for contract incentive | — | 350 |
| Reclassification of warrant liabilities to equity | — | 173 |
| Reclassification of customer deposit to debt | — | 230 |
| Reconciliation of cash, cash equivalents, and restricted cash to condensed consolidated balance sheets: | ||
| Cash and cash equivalents | $2,244 | $1,276 |
| Restricted cash and cash equivalents, current | 777 | 624 |
| Restricted cash and cash equivalents, non-current | 299 | 617 |
| Total cash, cash equivalents, and restricted cash | $3,320 | $2,517 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.